Livemint

US generics tariffs more negotiation tactic than real threat: Biocons Kiran Mazumdar-Shaw

The company, which is among the worlds top biosimilars manufacturers, remains in a wait-and-watch mode, while exploring partnerships for manufacturing in the US if required, Shaw said.